| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787742 | Journal of Thoracic Oncology | 2018 | 10 Pages |
Abstract
Concordance between the four programmed death ligand 1 immunohistochemical assays when performed and scored as intended show that apart from 28-8 and 22C3, they cannot be used interchangeably in clinical practice. A protocol was successfully developed to use 22C3 on an alternate platform, which may help to overcome some barriers to implementation.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Shona M.B.B.S., David J. BSc, Gavin M. PhD, Richard J. MSc, Sue BSc, Wendy A. PhD, Stephen B. DPhil,